Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

03 November 1997

Role of dopaminergic receptor agonists in the treatment of Parkinson's disease

Zygmunt Jamrozik, Piotr Janik

Med Sci Monit 1997; 3(6): RA948-955 :: ID: 501846

Abstract

The efficiency of long time treatment by levodop of Parkinson's disease (PD) is limited to occurrence of side syndromes in the form of movement disorders such as: fluctuations, diskinesia, the decrease of effectiveness of the drug. The causes of their occurrence connected with loss of dopaminergic cells, pharmacodynamics, pharmacokinetic of levodop, changes in affinity of dopamine receptors (D), pathology of other structures outside the nigrostrial pathways. The discovery of the family of dopamine receptors D1, D2, D3, D4 and D5 and their differentiated effect on the functions of exrapyramidal system allowed the use of the strategy of more selective reaction on particular receptors. Dopamine receptor agonists (DAAG) have some positive characteristics from the clinical point of view and theoretical comparison to levodop. Those drugs are not metabolized to active chemicals, do not produce toxic metabolites or free radicals, their effectiveness in a smaller degree is depended on degree of damage of presynaptic elements. DAAG effectively brings back the balance in the neurotransmission of neuropeptides in striatum and decrease rotation of endogenic dopamine. Among actually available DAAG at least three have potential neuroprotective action. Former clinical xperiments show that use of this drugs is particularly desirable in two groups of patients. First consists of young patients, that had been not treated yet, particularly successible to fast occurrence of levodopic complications, in whom the use of DAAG in monotherapy allows to decrease the risk of far complications. The second group consists of patients treaded with levadop, with developed side symptoms, which cannot be satisfactorily control with the help of antycholinergic drugs, amontadine, benzodiazapine.

Keywords: basal ganglia, dopaminergic receptor agonists

Add Comment 0 Comments

Editorial

01 April 2024 : Editorial  

Editorial: Forty Years of Waiting for Prevention and Cure of HIV Infection – Ongoing Challenges and Hopes for Vaccine Development and Overcoming Antiretroviral Drug Resistance

Dinah V. Parums

DOI: 10.12659/MSM.944600

Med Sci Monit 2024; 30:e944600

0:00

In Press

10 Apr 2024 : Clinical Research  

Predicting Acute Cardiovascular Complications in COVID-19: Insights from a Specialized Cardiac Referral Dep...

Med Sci Monit In Press; DOI: 10.12659/MSM.942612  

06 Mar 2024 : Clinical Research  

Enhanced Surgical Outcomes of Popliteal Cyst Excision: A Retrospective Study Comparing Arthroscopic Debride...

Med Sci Monit In Press; DOI: 10.12659/MSM.941102  

06 Mar 2024 : Clinical Research  

Prevalence and Variation of Medical Comorbidities in Oral Surgery Patients: A Retrospective Study at Jazan ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943884  

08 Mar 2024 : Clinical Research  

Evaluation of Foot Structure in Preschool Children Based on Body Mass

Med Sci Monit In Press; DOI: 10.12659/MSM.943765  

Most Viewed Current Articles

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750